BioPharm International - March 2021

BioPharm International - Regulatory Sourcebook - March 2021

Issue link: https://www.e-digitaleditions.com/i/1354372

Contents of this Issue

Navigation

Page 14 of 47

Specialized areas of focus: • Cytotoxics • Highly Potent Compounds • Antibody-Drug Conjugates (ADCs) • Biologics • Lyophilized Products Capabilities: • Lyophilization • Aseptic Powder Filling • Aseptic Liquid Filling • Sterile Crystallization • Liposomes/Emulsions Baxter is a registered trademark of Baxter International Inc. 920810-01 Visit our website at: baxterbiopharmasolutions.com Your Oncology Product Can Make a Difference in Patients' Lives Our oncology manufacturing expertise can help you make that difference. Baxter's facility in Halle/Westfalen, Germany, is dedicated to oncology products and is SafeBridge certified. Uniquely designed to deliver high-quality products with optimum efficiency and speed-to-market, we provide integrated technologies and services for clinical to commercial production. With over 60 years of experience, we are focused on excellence in oncology manufacturing.

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - March 2021 - BioPharm International - Regulatory Sourcebook - March 2021